ArticleTurk gogus kalp damar cerrahisi dergisi2026
Survival impact of pN2a and pN2b nodal status in stage IIB-IIIB non-small cell lung cancer under the 9
Article in Turk gogus kalp damar cerrahisi dergisi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Surgical resection in non-small cell lung cancer (NSCLC) is a potentially curative option in selected patients. Current TNM staging systems emphasize the prognostic role of pathological N (pN) status, and in the 9 Methods: A total of 824 patients aged ≥18 years who underwent lung resection for NSCLC between 2007 and 2021 and were stage IIB, IIIA, or IIIB according to the 8 Results: The mean age was 59.7±8.58 years; 10.4% of patients were female. Squamous cell carcinoma (61.7%) and adenocarcinoma (32.5%) were the most common histologies. Lobectomy, pneumonectomy, and segmentectomy were performed in 52.3%, 46.8%, and 0.8% of patients, respectively. Age >70 years (p<0.001) and adenocarcinoma histology (p<0.001) were associated with worse survival, whereas gender and type of resection were not. pN2 disease had significantly worse survival than pN1 (p<0.001). In the 9 Conclusion: pN status, particularly pN2 subgroups in the 9
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.